Risk of all-cause and HF death was significantly reduced in patients with METS compared to patients without METS ( HR : 0.83 , 95 % CI : 0.72 to 0.95 , p = 0.005 ; HR : 0.76 , 95 % CI : 0.59 to 0.98 , p = 0.031 ; respectively ) .